Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials

Background: Sleep disorders are one of the most frequent non-motor symptoms of Parkinson's disease (PD), and the efficacy of dopaminergic agents remains controversial. Clinical randomized control trials for the treatment of sleep disorders in PD are limited. Zonisamide (1,2-benzisoxazole-3-meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Hiroshi, Isogawa, Masahiro, Inoue, Takashi, Hasebe, Miyoko, Takashima, Ryuzo, Kasama, Shu, Nanaura, Hitoki, Kiriyama, Takao, Kasahara, Masato, Sugie, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713296/
https://www.ncbi.nlm.nih.gov/pubmed/34970203
http://dx.doi.org/10.3389/fneur.2021.741307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713296/
https://www.ncbi.nlm.nih.gov/pubmed/34970203
http://dx.doi.org/10.3389/fneur.2021.741307

Ejemplares similares